Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Helmholtz Munich is a leading German research center organized as a GmbH that focuses on environmental health, particularly the interaction between genetics, environmental factors, and lifestyle. The center is a major hub for biomedical innovation, specializing in metabolic diseases like diabetes and obesity, as well as chronic lung diseases and allergies. It operates as a bridge between basic research and clinical application, frequently spinning off biotech companies and partnering with global pharmaceutical firms to develop novel therapeutics. Helmholtz Munich utilizes advanced platforms in drug discovery, artificial intelligence, and single-cell analysis to identify new drug targets and therapeutic modalities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Center for Environmental.